Biomerica Profit Reflects 14% Increase in Revenue

NEWPORT BEACH — Biomerica Inc., a Newport Beach manufacturer of medical diagnostic products, reported a profit of $31,103, or 1 cent a share, for its second fiscal quarter, which ended Nov. 30. That contrasted with a loss of $35,987, or 1 cent a share, for the same period a year earlier.

Revenue increased 14% to $2.4 million from $2.1 million. For the first half, profit totaled $32,392, or 1 cent a share, contrasted with a loss of $125,305, or 4 cents a share, for the same period a year earlier. Six-month revenue was up 12% to $4.6 million from $4.1 million.